Stockscreener 앱 받기
0.7302
44.68%
-0.5898
전일 마감가:
$1.32
열려 있는:
$0.9856
하루 거래량:
194.65M
Relative Volume:
6.89
시가총액:
$35.82M
수익:
-
순이익/손실:
$-16.26M
주가수익비율:
-0.6181
EPS:
-1.1814
순현금흐름:
$-13.50M
1주 성능:
+206.94%
1개월 성능:
+200.87%
6개월 성능:
+24.16%
1년 성능:
-77.53%
1일 변동 폭
$0.70
$1.15
1주일 범위
$0.23
$1.74
52주 변동 폭
$0.1853
$3.40
인텐시티 테라퓨틱스 Stock (INTS) Company Profile
명칭
Intensity Therapeutics Inc
전화
203-221-7381
주소
1 ENTERPRISE DRIVE, SUITE 430, SHELTON
INTS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INTS
Intensity Therapeutics Inc
|
0.7302 | 64.75M | 0 | -16.26M | -13.50M | -1.1814 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | -52.09M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
인텐시티 테라퓨틱스 주식(INTS)의 최신 뉴스
Ranking Intensity Therapeutics Inc. among high performing stocks via toolsMarket Growth Report & Daily Volume Surge Signals - newser.com
How Intensity Therapeutics Inc. stock performs in stagflationJuly 2025 Review & Low Drawdown Trading Strategies - newser.com
How Intensity Therapeutics Inc. stock trades before earnings2025 Breakouts & Breakdowns & AI Powered Market Entry Strategies - newser.com
Using Bollinger Bands to evaluate Intensity Therapeutics Inc.2025 Sector Review & Precise Swing Trade Alerts - newser.com
Intensity Therapeutics surges 395% on phase 1/2 data for solid tumors asset - MSN
How to track smart money flows in Intensity Therapeutics Inc.2025 AllTime Highs & Verified Momentum Stock Alerts - newser.com
How interest rate cuts could boost Intensity Therapeutics Inc. stock2025 Top Decliners & Community Verified Trade Alerts - newser.com
Intensity Therapeutics Enters Securities Purchase Agreement - TipRanks
INTS to raise $4.0M via 5,000,000-share registered direct sale - Stock Titan
Intensity Therapeutics announces pricing of $4M registered direct offering of common stock - MSN
Intensity Therapeutics Prices $4 Million Direct Offering - MarketScreener
Intensity Therapeutics prices 5M shares at 80c in registered direct offering - TipRanks
Intensity Therapeutics shares plunge 30% after $4 million discounted stock offering - MSN
Intensity Therapeutics, Inc. (INTS) stock tumbles 30% as $4M direct offering sparks investor concern - parameter.io
Unexpected Surge: Analyzing INTS Performance - timothysykes.com
Intensity Therapeutics prices $4 million registered direct offering By Investing.com - Investing.com Australia
Intensity Therapeutics prices $4 million registered direct offering - Investing.com
Intensity Therapeutics, Inc. Trade Ideas — NASDAQ:INTS - TradingView
Intensity Therapeutics stock tumbles after pricing $4 million offering By Investing.com - Investing.com Nigeria
Intensity Therapeutics stock tumbles after pricing $4 million offering - Investing.com
Intensity Therapeutics stock up nearly 400% on solid tumour data - Yahoo Finance
Intensity Therapeutics, Inc. Announces Pricing of $4 Million Registered Direct Offering of Common Stock - PR Newswire
Is Intensity Therapeutics Inc. stock oversold or undervaluedJuly 2025 Reactions & Consistent Income Trade Recommendations - newser.com
Why Intensity Therapeutics Inc. stock is favored by top institutionsWeekly Market Report & AI Optimized Trade Strategies - newser.com
Trending tickers: Apple, Amazon, Netflix, Reddit and Intensity Therapeutics - Yahoo! Finance UK
Volume spikes in Intensity Therapeutics Inc. stock – what they meanMarket Sentiment Review & Technical Entry and Exit Alerts - newser.com
How to integrate Intensity Therapeutics Inc. into portfolio analysis toolsEarnings Miss & Verified Trade Idea Suggestions - newser.com
Intensity Therapeutics Stock Cools After-Hours Following 395% Surge: What You Should Know - inkl
Does Intensity Therapeutics Inc. show high probability of reboundPortfolio Profit Report & Weekly Hot Stock Watchlists - newser.com
US Stock Market top gainers and losers on October 30: Intensity Therapeutics, Inc. sees nearly 400% jump, - The Economic Times
Positive Phase 1/2 clinical data for cancer candidate drug propels Intensity Therapeutics (INTS.US) stock up by 395%. - 富途牛牛
Why Is Retail Going Gaga Over INTS Stocks Today? - Stocktwits
Intensity Therapeutics Shares Soar on Promising Cancer Trial Results - El-Balad.com
Intensity Therapeutics publishes cancer treatment study results in Lancet journal By Investing.com - Investing.com South Africa
Intensity Therapeutics shares skyrocket after strong cancer drug trial results - Business Upturn
Intensity Therapeutics shares more than double on promising cancer trial data - TradingView
Intensity Therapeutics stock soars after phase 1/2 data publication By Investing.com - Investing.com Philippines
Intensity Therapeutics stock soars after phase 1/2 data publication - Investing.com
Intensity Therapeutics, Inc. (INTS) Stock: Soars 182% After Landmark Lancet Publication on Breakthrough Cancer Therapy - parameter.io
Tiny Biotech INTENSITY THERAPEUTICS Stock Skyrockets on Cancer Therapy Breakthrough – Experts See Big Upside - ts2.tech
Why Is Intensity Therapeutics Stock (INTS) Up 195% Today? - TipRanks
Intensity Therapeutics’ INT230-6 antitumor effect featured in published study - TipRanks
Intensity Therapeutics publishes cancer treatment study results in Lancet journal - Investing.com
인텐시티 테라퓨틱스 (INTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):